Medicine and Science News Releases

View recent medicine and science-related news releases.

 
04/11/2014
St. Jude Children’s Research Hospital named national center of excellence for flu research

St. Jude again designated Center of Excellence for Influenza Research and Surveillance by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

 
 
04/06/2014
Gene sequencing project discovers mutations tied to deadly brain tumors in young children

St. Jude Children’s Research Hospital-Washington University Pediatric Cancer Genome Project offers new leads to improved outcomes for children with high-grade glioma brain tumors; particularly youngest patients. (Suzanne Baker, PhD, and Jinghui Zhang, PhD)

 
 
04/03/2014
Tumor suppressor gene TP53 mutated in 90 percent of most common childhood bone tumor

St. Jude Children’s Research Hospital—Washington University Pediatric Cancer Genome Project finds TP53 gene is altered in nearly all osteosarcomas; results help explain how tumors withstand radiation therapy. (Michael Dyer, PhD, and Jinghui Zhang, PhD)

 
 
03/27/2014
Adult cancer drugs show promise against an aggressive childhood brain tumor

A St. Jude Children’s Research Hospital-led study identified two adult cancer drugs with potential to improve treatment of a high-risk childhood brain tumor; the drugs are now part of a pediatric clinical trial. (Martine Roussel, PhD)

 
 
03/17/2014
Health gap between adult survivors of childhood cancer and siblings widens with age

St. Jude Children’s Research Hospital and the Childhood Cancer Survivor Study: Long-term follow-up of adult survivors of childhood cancer reinforces need for lifelong health surveillance for childhood cancer survivors. (Gregory Armstrong, MD)

 
 
02/19/2014
Gene sequencing project discovers common driver of a childhood brain tumor

St. Jude Children’s Research Hospital -Washington University Pediatric Cancer Genome Project identifies the most common genetic alteration yet in the brain tumor ependymoma; results offer clues for fighting other cancers. (Richard Gilbertson, MD, PhD, David Ellison, MD, PhD, Jinghui Zhang, PhD)

 
 
02/10/2014
Researchers discover immune signature that predicts poor outcome in influenza patients

A study led by St. Jude Children’s Research Hospital identifies factors that predict flu severity in patients and sets the stage for more effective therapies to prevent flu complications and deaths (Paul Thomas, PhD)

 
 
02/05/2014
Mechanism discovered for how amyotrophic lateral sclerosis mutations damage nerve function

A study led by St. Jude Children’s Research Hospital offers a new avenue for scientists to pursue in the quest for desperately needed treatments for ALS. (J. Paul Taylor, MD, PhD)

 
 
01/27/2014
Promising class of antibiotics discovered for treatment of drug-resistant tuberculosis

Research led by St. Jude Children’s Research Hospital scientists has produced new versions of an old antibiotic that are active against difficult-to-treat tuberculosis; offers new strategy for overcoming drug resistance. (Richard Lee, PhD)

 
 
01/21/2014
Cancer diagnosis doesn’t increase a child’s risk of post-traumatic stress disorder

St. Jude Children’s Research Hospital study suggests previous research overestimated PTSD in young cancer patients; new findings highlight the ability of children to adjust and even thrive in response to challenges. (Sean Phipps, PhD)

 
 
01/16/2014
St. Jude Children’s Research Hospital makes FORTUNE magazine “100 Best Companies to Work For” list for fourth year

St. Jude Children’s Research Hospital has been recognized for the fourth consecutive year as one of FORTUNE magazine’s “100 Best Companies to Work For.”

 
 
12/16/2013
Researchers discover how a protein complex revs up T cell activation to fight infections

St. Jude Children’s Research Hospital scientists find mechanism that launches production of the specialized T cells essential for combating infectious agents and that offers new therapeutic possibilities. (Dr. Hongbo Chi)

 
 
12/09/2013
Gene sequencing project finds family of drugs with promise for treating childhood tumor

St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project study identifies drugs that enhance oxidative stress as possible weapon against most common pediatric soft tissue tumor. (Dr. Michael Dyer)

 
 
12/03/2013
Gene therapy bolsters enzyme activity to combat Alzheimer’s disease in mice

St. Jude Children’s Research Hospital scientists identify enzyme that could lead to better diagnosis and treatment of Alzheimer’s disease and related disorders. (Dr. Alessandra d'Azzo)

 
 
12/02/2013
1950s pandemic influenza virus remains a health threat, particularly to those under 50

St. Jude Children’s Research Hospital scientists report that avian H2N2 influenza A viruses related to 1957-1958 pandemic infect human cells and spread among ferrets; may aid identification of emerging threats. (Dr. Robert Webster)

 
 
11/18/2013
Adult survivors of childhood cancer at risk of becoming frail at an early age

St. Jude Children’s Research Hospital study finds that young adults who had cancer as children are more likely to be frail than their peers; this condition leaves survivors at increased risk of death and chronic disease. (Dr. Kirsten Ness)

 
 
11/15/2013
Drug offers promising approach to improve outcome for children with high-risk leukemia

St. Jude Children’s Research Hospital leads study showing that a drug withdrawn from the market in 2010 may enhance the effectiveness of bone marrow transplants for select pediatric leukemia patients. (Dr. Jeffrey Rubnitz)

 
 
10/21/2013
St. Jude Children’s Research Hospital scientific director elected to Institute of Medicine

James R. Downing, M.D., becomes hospital’s sixth IOM member

 
 
10/20/2013
Inherited gene variation tied to high-risk pediatric leukemia and greater risk of relapse

Study led by St. Jude Children’s Research Hospital finds an inherited gene variation—more common among Hispanic Americans–is tied to increased risk of developing a high-risk form of pediatric leukemia. (Dr. Jun Yang)

 
 
10/20/2013
Research offers new insight in quest for single vaccine against multiple influenza strains

A study led by St. Jude Children’s Research Hospital identifies new path to a universal influenza vaccine emphasizing production of broadly specific antibodies that target multiple flu viruses. (Dr. Maureen McGargill)

 
 
10/10/2013
Preventable risk factors pose serious threat to heart health of childhood cancer survivors

A Childhood Cancer Survivors Study led by St. Jude Children’s Research Hospital suggests that reducing risk factors like hypertension might lower the risk of heart disease for survivors as they age. (Dr. Greg Armstrong)

 
 
10/10/2013
St. Jude Children’s Research Hospital names new chief legal officer

Robyn Diaz, J.D., tapped to serve as chief legal officer and senior vice president.

 
 
10/09/2013
St. Jude Children’s Research Hospital scientist recognized by American-Italian Cancer Foundation

Charles J. Sherr, M.D., Ph.D., to receive the Prize for Scientific Excellence in Medicine by the American-Italian Cancer Foundation.

 
 
09/26/2013
St. Jude Children’s Research Hospital appoints new clinical director

Larry Kun, M.D., to oversee all aspects of patient care and clinical services at the hospital.

 
 
09/16/2013
Immune system marker tied to improved bone marrow transplant outcomes

St. Jude Children’s Research Hospital investigators prove that an immune marker predicts transplant success and improves selection of bone marrow donors (Dr. Wing Leung)

 
 
09/16/2013
St. Jude Children’s Research Hospital CEO announces retirement

Dr. William E. Evans will retire from executive post in July 2014.

 
 
09/09/2013
Rare, inherited mutation leaves children susceptible to acute lymphoblastic leukemia

Research from St. Jude Children’s Research Hospital, Memorial Sloan-Kettering Cancer Center and the University of Washington identifies a mutation that predisposes individuals to most common form of childhood leukemia. (Dr. Charles Mullighan)

 
 
09/02/2013
Drug reduces hospitalizations and cost of treating young children with sickle cell anemia

The St. Jude Children’s Research Hospital-led national BABY HUG trial linked hydroxyurea to a 21 percent reduction in annual medical costs for young children with sickle cell anemia; savings expected to grow. (Dr. Winfred Wang)

 
 
09/02/2013
St. Jude Children’s Research Hospital recognizes Childhood Cancer Awareness Month

At St. Jude, doctors and scientists work to improve childhood cancer survival rates as well as enhance patients’ long-term quality of life after treatment.

 
 
08/29/2013
St. Jude Children’s Research Hospital study yields new strategy against high-risk leukemia

After identifying a protein that blocks death of high-risk acute lymphoblastic leukemia (ALL) cells, scientists use two-drug combination therapy to offer hope to children and adults with the disease. (Dr. Joseph Opferman)

 
 
08/08/2013
Understanding mutation leads to promising new treatment for autoinflammatory diseases

St. Jude Children’s Research Hospital study yields clues for designing next-generation drugs to treat autoinflammatory diseases. (Dr. Kanneganti)

 
 
08/04/2013
Mechanism offers promising new approach for harnessing the immune system to fight cancer

St. Jude Children’s Research Hospital researchers discover how to unleash the immune system against cancer in model system without triggering autoimmune reactions. (Dr. Dario Vignali)

 
 
08/02/2013
St. Jude creates $5.5 million endowment for cancer research to be held by the hospital CEO

The Donald Pinkel Endowed Chair of Pediatric Cancer Treatment honors first director of St. Jude and is among the largest endowed chairs in the nation.

 
 
07/10/2013
Protein targeted for cancer drug development is essential for normal heart function

St. Jude Children’s Research Hospital discovers a role for a protein in research that has implications for treatment of cancer and heart disease. (Dr. Joseph Opferman)

 
 
07/03/2013
Maintaining immune balance involves an unconventional mechanism of T cell regulation

St. Jude Children’s Research Hospital study challenges prior understanding of the process regulating specialized T cells that are essential for a balanced immune system. (Dr. Hongbo Chi)

 
 
06/13/2013
St. Jude Children’s Research Hospital postdoctoral fellow named Pew Latin American Fellow

Andres Herrada, Ph.D., a postdoctoral fellow in the Department of Immunology at St. Jude Children’s Research Hospital, has been named a Pew Latin American Fellow in the Biomedical Sciences by The Pew Charitable Trusts.